Djursing

Time to BUY. (-8.14% today)

看多
Djursing 已更新   
OMXCOP:NOVO_B   NOVO NORDISK B A/S
評論:
Novo Nordisk got rejected by USA (something to do with 'insulin'), which is why we have such a high decline in price(the market overreacting to news). It is not uncommon to be rejected the first couple of times, but If you want to make some money in the medium-long term, this stock is something to consider!

Novo Nordisk is an overall solid stock!
Second most traded stock in Denmark(right after Genmab).
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。